SynopsisSarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function. The global Sarcopenia Therapeutic market was valued at US$ 2762.8 million in 2023 and is anticipated to reach US$ 3670 million by 2030, witnessing a CAGR .....
SynopsisThe global Wound Closure market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Wound Closure is estimated to increase from $ millio.....
Synopsis MPS, also known as mucopolysaccharidosis, refers to a group of key rare metabolic disorders which is caused by the absence, deficiency or malfunctioning of lysosomal enzymes called glycosaminoglycan (GAGs). The global Mucopolysaccharid.....
SynopsisMPS, also known as mucopolysaccharidosis, refers to a group of key rare metabolic disorders which is caused by the absence, deficiency or malfunctioning of lysosomal enzymes called glycosaminoglycan (GAGs). The global Mucopolysaccharidosis Therapeutics m.....
SynopsisNon-Hodgkin’s lymphomas are one of the most commonly occurring cases of lymphomas and hence is also one of the most commonly occurring cancers. If not treated effectively, it is potentially lethal and leads to a shorter life span of the individuals diagnosed.
SynopsisA stoma is an artificial opening structure that connects the internal luminal organs, such as the intestine or ureter, and the outside of the body to ensure the discharge of feces or urine. According to its function, it is also called an artificial anus or an .....
Synopsis An ostomy is a surgical procedure undertaken to create an opening or stoma on the abdominal wall for waste products to move out of the body. It is useful in case of certain diseases of the digestive and urinary system. Ostomy can either be tem.....
SynopsisSpinal muscular atrophy treatment market growth is driven by a significant increase in the number of product launches despite the relative rarity of the disorder and high costs associated with the approved drugs. The treatment of spinal muscular atrophy throug.....
SynopsisStomach cancer is the fifth most common cancer in the world The global Stomach Cancer and Gastric Cancer Treatment market was valued at US$ 3948 million in 2023 and is anticipated to reach US$ 9059.7 million by 2030, witnessing a CAGR of 12.6% during the.....
SynopsisStomach cancer is the fifth most common cancer in the world The global Stomach Cancer and Gastric Cancer Drugs market was valued at US$ 3948 million in 2023 and is anticipated to reach US$ 9059.7 million by 2030, witnessing a CAGR of 12.6% during the for.....
